|
Alintegimod Clinical Trials
1 actively recruiting trial across 1 location
Also known as: 7HP349
Lake Mary, Florida1 trial
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Florida Cancer Specialists
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.